Compound Detail

CHEMBL4742986

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

Cl.N#Cc1ccc(S(=O)(=O)N2CC3=C(NC(N)=NC3c3cccc(F)c3)/C(=C/c3cccc(F)c3)C2)cc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4742986
Phase	Preclinical
Structure Type	MOL
InChI Key	IXWWZUFZKCGCBV-DOELHFPHSA-N
Parent Compound	CHEMBL4802461
Active Moiety	CHEMBL4802461

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

517.6

MW (Da)

3.84

ALogP

HBA

HBD

111.6

PSA (Å²)

0.55

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 5.46

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HepG2 CHEMBL395	IC50	5.46	5.46	3500.0	1
SMMC-7721 CHEMBL613831	IC50	5.38	5.38	4200.0	1
L02 CHEMBL4296457	IC50	4.76	4.76	17200.0	1
Unchecked CHEMBL612545	IC50	4.72	4.72	18900.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HepG2	IC50	=	3500.0	nM	5.46	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i...	32371335
SMMC-7721	IC50	=	4200.0	nM	5.38	Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viabili...	32371335
L02	IC50	=	17200.0	nM	4.76	Cytotoxicity against human L02 cells assessed as reduction in cell viability inc...	32371335
Unchecked	IC50	=	18900.0	nM	4.72	Cytotoxicity against human HHL-5 cells assessed as reduction in cell viability i...	32371335

PubMed	DOI	Target Context	# Activities
32371335	10.1016/j.ejmech.2020.112366	RAW264.7	3
32371335	10.1016/j.ejmech.2020.112366	HepG2	1
32371335	10.1016/j.ejmech.2020.112366	SMMC-7721	1
32371335	10.1016/j.ejmech.2020.112366	Unchecked	1
32371335	10.1016/j.ejmech.2020.112366	L02	1

Data from ChEMBL 36 via Core Engine